NEW DELHI/HYDERABAD: The nation’s drug regulator has authorised vaccine-maker Biological E’s Corbevax for emergency use among children in the 12-17 age group, making a third shot available in the coronavirus…
New Delhi, Feb 19 (PTI) Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US. In a statement, Ocugen Inc, Bharat Biotech’s…
NAGPUR: The drive for 15+ years group remained affected on Friday at many centres as doses were received late on Wednesday evening and sessions couldn’t be planned in schools and…
Nagpur: Many centres in the city couldn’t conduct vaccination session for the 15 to 17 as well as 18+ age groups on Saturday after running out of Covaxin doses by…
Bharat Biotech has sought from the Drugs Controller General of India regular market approval for its COVID-19 vaccine ‘Covaxin’, which is currently only authorised for emergency use in the country,…
Hyderabad : Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines for infectious diseases, Saturday announced that Covaxin whole-virion inactivated COVID-19 vaccine clinical trial…
Some healthcare specialists, who are entitled to get precautionary vaccine doses from January 10, have expressed concern over the government’s decision to use the same vaccine as the third dose.…
The Central Drugs Standard Control Organisation (CDSCO) has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking to 12 the number of preventives and…
BENGALURU: The Union health ministry’s categorical assertion that no vaccine, including those for Covid-19, should be used beyond expiry date as mentioned on the label of their vials has led…
Two government vaccine makers, Haffkine Bio-Pharmaceutical Corporation and Bharat Immunologicals and Biologicals Corporation (BIBCOL), that signed up to produce Bharat Biotech’s Covaxin drug substance may not be in a position…
